• Thu, May 5, 2022
Dane Leone Maintained (ALLO) at Buy with Decreased Target to $13 on, May 5th, 2022
Dane Leone of Raymond James, Maintained "Allogene Therapeutics, Inc." (ALLO) at Buy with Decreased Target from $36 to $13 on, May 5th, 2022.
Dane has made no other calls on ALLO in the last 4 months.
There is 1 other peer that has a rating on ALLO. Out of the 1 peers that are also analyzing ALLO, all agrees with Dane's Rating of Hold. Following is the relevant analyst calls for the last 4 months
- Salveen Richter of "Goldman Sachs" Maintained at Hold with Decreased Target to $12 on, Monday, March 7th, 2022